Skip to main content

Faculty Profile

ononogbu-onye-21.jpgOnyebuchi J. Ononogbu

Research Assistant Professor,
Department of Pharmacy Practice and Translational Research
Hematology/Oncology Clinical Pharmacy Specialist,
Harris Health System

University of Houston College of Pharmacy
Health 2, Room 4043
4349 Martin Luther King Boulevard
Houston, TX 77204-5039

Contact: - 832-842-8384


  • Cancer Health Disparities
  • Quality Improvement
  • Diversity/Equity
  • Inclusion
  • Board Certified Oncology Pharmacist, Board of Pharmacy Specialties
  • ASHP PGY-1 Pharmacy Practice Resident, Howard University Hospital, Washington, D.C.
  • Doctor of Pharmacy, University of the Incarnate Word Feik School of Pharmacy, Cum Laude, San Antonio, TX,
  • Bachelor of Science in Allied Health and Diagnostic Sciences, University of Connecticut, Storrs, CT


Google Scholar Profile

  • Rahimi S, Ononogbu O, Mohan A, Moussa D, Abughosh S, Trivedi M. Identifying the predictors of adherence to oral endocrine therapy in racial/ethnic minority patients with low socioeconomic status. Res Sq. 2022 Dec doi: 10.21203/
  • Apostolidou E, Lachowiez C, Juneja H, Qiao W, Ononogbu O, Miller-Chism C, Udden M, Ma H, Mims M. Clinical outcomes of patients with newly diagnosed acute lymphoblastic leukemia in a county hospital system. Clinical Lymphoma, Myeloma and Leukemia. 2021 Nov;21(11):e895-e902. doi: 10.1016/j.clml.2021.06.022.
  • Nguyen T, Ononogbu O, Egwim O, Saffari F, Ferrer J. Reducing chemotherapy administration time on an inpatient oncology unit. J Oncol Pharm Pract. 2021 Dec;27(8):1878-1882. doi: 10.1177/1078155220971737.
  • Wiele A, Nguyen T, Ononogbu O. Reducing the wait time to initiate inpatient chemotherapy at Lyndon B. Johnson Hospital (Abstract). Journal of Clinical Oncology.2020 38:29_suppl, 210-210.
  • Adigun M, Adesoye A, Ayoola A, Lteif L, Amaechi O. Review of Nonneurogenic Overactive Bladder, Continuing Education. US Pharmacist. Aug 2014.

Abstracts and Poster Presentations

  • Nguyen T, Ononogbu, O. (July 2018). Reducing chemotherapy administration time on an inpatient oncology unit. Presentation at ALCALDE Meeting. Webinar.
  • Sirisaegtaksin, A., Ononogbu, O. (December 2017). Assessment of hypersensitivity reactions with rituximab used at a quaternary medical center. Presentation at Midyear Conference. Orlando, Florida.
  • Amaechi, O., Adigun, M. (December 2013). Impact of a pharmacist-driven medication reconciliation program at a tertiary teaching institution. Presentation at ASHP Midyear Conference. Orlando, Florida.
  • Amaechi, O., Lopez, T., Anosike, P., Ha, H. (December 2012). Evaluation of the Readability of Discharge Warfarin Information. Presentation at ASHP Midyear Conference. Las Vegas, Nevada.
  • Amaechi, O., Ha, H., Anosike, P., (July 2012). Evaluation of the Readability of Consumer Medication Information. Presentation at the SNPhA/NPhA National Conference. Las Vegas, Nevada
  • Amaechi, O., Lee, I.C., Copenhaver, M. (June 2008). A Brief Behavioral Intervention to Enhance Medication Adherence Among HIV-infected Injection Drug Users. Presentation at the College on Problems of Drug Dependence (CPDD) annual conference. San Juan, Puerto Rico.

Awards & Honors

  • Patient Advocate Award, American College of Clinical Pharmacy Hematology/Oncology Practice and Research Network, 2022
  • Clinical Safety & Effectiveness Course, University of Texas MD Anderson Cancer Center, 2020
  • Biomedical Informatics Certificate, UTHealth Houston, 2018
  • Preceptor of the Year, Baylor St. Luke’s Medical Center, 2018
  • Co-Founder, Pharmacy Initiative Leaders (PILs), 2016 - present
  • Hematology Oncology Pharmacy Association, 2018 - present
  • American Society of Health-System Pharmacists, 2013 - present
  • Phi Lambda Sigma Pharmacy Leadership Society, 2011 - present